We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sign up to read this article for FREE!

After signing up, you'll start to receive regular news updates from us.

Sigma-Aldrich Expands Panorama™ Array Product Line

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Sigma-Aldrich has launched the Panorama™ p53 Pathways Antibody Array for studying the expression patterns of proteins known to be involved in p53 pathways.

The array is designed to enable the analysis of cell or protein extracts and contains 112 antibodies spotted in duplicate onto a nitrocellulose slide along with Cy™3 and Cy5 positive controls and a negative control.

The recognition of p53 as a pivotal regulatory protein involved in a variety of signaling pathways is crucial to understanding the development and progression of cancer.

Sigma-Aldrich's array will enable researchers to study the complex nature of p53 pathways in an efficient manner and allow the identification of protein expression patterns that may be related to cancer.

"Given the tremendous amount of information regarding all aspects of normal p53 function and mutant expression in cancers, we are pleased to offer the first targeted p53 Pathways Antibody Array," said Alicia Pruett, Product Manager, Array Technology.

"We are committed to providing cutting-edge proteomics tools to the research community and will continue to develop and market innovative products such as the p53 Pathways Array in order to accelerate scientific research."